SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-19-013073
Filing Date
2019-06-07
Accepted
2019-06-07 16:51:18
Documents
1
Period of Report
2019-06-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4041
  Complete submission text file 0001567619-19-013073.txt   5499
Mailing Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746
Business Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Issuer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LILLY VENTURES FUND I, LLC 115 W. WASHINGTON STREET,STE 1680-SOUTH INDIANAPOLIS IN 46204
Business Address
Shanafelt Armen (Reporting) CIK: 0001656151 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37722 | Film No.: 19886577